marijuana stocks news

Cara Therapeutics to Webcast Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference

Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present a company overview at Cantor Fitzgerald’s 2ndAnnual Healthcare Conference on Tuesday, July 12, 2016, at 1:00 p.m. ET in New York City.

A live webcast of the presentation can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated initial efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.

Contact:
INVESTOR CONTACT:
Jesse Baumgartner
Stern Investor Relations, Inc.
212-362-1200 
Jesse@sternir.com

MEDIA CONTACT: 
Annie Starr
6 Degrees
973-415-8838 
astarr@6degreespr.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

INSYS Therapeutics, Inc. (INSY) Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities

INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy…

Cresco Labs (CRLBF) Announces Three New Sunnyside Dispensaries in Florida

Cresco Labs Announces Three New Sunnyside Dispensaries in Florida Cresco Labs (CSE:CL)…

High Tide Inc. (HITI) Announces At-The-Market Facility of up to CAD$40,000,000 for Strategic Initiatives

High Tide Announces At-The-Market Facility of up to CAD$40,000,000 for Strategic Initiatives…